Cerevast Therapeutics
Latest round
- Series C
Last raised
- Nov 2014
Total raised
- $5M
Investors
- 1
About Cerevast Therapeutics
Cerevast Therapeutics, Inc. is focused on developing advanced ultrasound therapies.38 mn.Cerevast's primary focus is on innovative healthcare solutions aimed at treating conditions related to retinal vein occlusion (RVO) and stroke. The company's core product offerings include microsphere-mediated ophthalmic ultrasound and transcranial ultrasound therapies, which leverage advanced ultrasound technology to enhance thrombolysis and neuromodulation. These solutions are designed to improve patient outcomes by targeting specific areas within the body to promote healing and restore health. The end users of these services primarily consist of healthcare providers and medical institutions that serve patients suffering from ocular and neurological conditions.Cerevast generates revenue through a structured business model that encompasses both direct sales and strategic partnerships with healthcare providers. Transactions typically involve the selling of proprietary medical devices and therapies, with a focus on securing contracts with hospitals and clinics that incorporate these innovative solutions into their treatment protocols. The pricing structure for Cerevast's services is aligned with the value provided through improved patient outcomes and operational efficiencies. Flagship offerings, such as the microsphere-mediated ophthalmic ultrasound, are marketed under trademarked names, providing the company with branding leverage in the competitive healthcare marketplace. The company is focusing on expanding into new markets, particularly in Europe and Asia, by 2025.
Who invested in Cerevast Therapeutics
1 investor across 1 round
See all investors in Cerevast Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 24, 2014
Amount
$5M
Investors
Questions about Cerevast Therapeutics
Who invested in Cerevast Therapeutics?
Cerevast Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cerevast Therapeutics raised?
Cerevast Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cerevast Therapeutics last raise money?
Cerevast Therapeutics's most recent round on record is a Series C, in Nov 2014.
What does Cerevast Therapeutics do?
Cerevast Therapeutics is a medical devices & equipment company.
Where is Cerevast Therapeutics headquartered?
Cerevast Therapeutics is headquartered in Redmond, US.
Which VCs invest in companies like Cerevast Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Cerevast Therapeutics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Cerevast Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.